These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Comparative evaluation of several functional tests of the liver in patients with pulmonary tuberculosis with side-reactions to tuberculostatic preparations]. Kaminskaia GO, Karachunskiĭ MA, Kolosovskaia VP. Ter Arkh; 1969 Nov; 41(11):75-9. PubMed ID: 5384752 [No Abstract] [Full Text] [Related]
6. [Kidney function in patients with pulmonary tuberculosis during treatment with antitubercular agents, with special reference to pyrazinamide]. Spychalski W, Grzegorzewska A, Westfal I. Pneumonol Pol; 1987 Oct; 55(10):454-7. PubMed ID: 3438179 [No Abstract] [Full Text] [Related]
9. Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection. Stout JE. Expert Opin Drug Saf; 2004 May; 3(3):187-98. PubMed ID: 15155147 [Abstract] [Full Text] [Related]
12. Effects of age, sex and alcoholic habit of patients on liver enzymes during antituberculosis chemotherapy. Aggarwal NP, Kallan BM, Aggarwal M, Joshi R. J Indian Med Assoc; 1991 Nov; 89(11):311-2. PubMed ID: 1787318 [No Abstract] [Full Text] [Related]
13. [Pyrazinamide-containing initial intensive short course chemotherapy of pulmonary tuberculosis]. Wada M. Kekkaku; 1997 Oct; 72(10):587-95. PubMed ID: 9386358 [Abstract] [Full Text] [Related]